Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company with ...

The Biotechnology Program was founded on a vision to prepare ... the symposium began with a networking lunch and research posters presented by high school and undergraduate students. Welcome remarks ...

Tonix Pharmaceuticals (NASDAQ: TNXP) a fully integrated biotechnology company with commercial and clinical-stage assets, will deliver a poster presen ...

A colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

About MAIA Biotechnology, Inc. MAIA is a targeted ... progress and results of our preclinical and clinical studies and our research and development programs, (ii) our ability to advance product ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.caNews Commentary – As traditional research institutions face growing budget constraints, the burden of advan ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

Another factor that may be contributing to the decline in publishing by industry medicinal chemists is the fact that ...

The study abstracts were published on the ASCO website on May 22, 2025 (CDT), with key highlights summarized below: ...

As shown in table 2, both OS and CBR values were in line or higher than those reported in the treatment arm of the ASCENT ...